Duvelisib (Copiktra)

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 03:28, 6 January 2015 by Jwarner (talk | contribs) (Jwarner moved page IPI-145 to Duvelisib (IPI-145))
Jump to navigation Jump to search

Mechanism of action

PI3K-δ,γ inhibitor

Preliminary data

Chronic lymphocytic leukemia

  1. Abstract: Manish Patel, Brad S. Kahl, Steven M. Horwitz, Francine M. Foss, Yasuhiro Oki, Pierluigi Porcu, Jennifer Sweeney, Kerstin Allen, Kerrie Faia, Patricia Harris, Joi Dunbar, Howard M. Stern, Patrick Kelly, Susan O'Brien. Preliminary Safety and Efficacy Of IPI-145, a Potent Inhibitor Of Phosphoinositide-3-Kinase-δ,γ, In Patients With Chronic Lymphocytic Leukemia. Blood Nov 2013,122(21)677 link to original abstract